- Home
- XENE vs FBP Comparison
XENE vs FBP Comparison
Compare XENE & FBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XENE | FBP |
|---|---|---|
| Founded | 1996 | 1948 |
| Country | Canada | United States |
| Employees | N/A | 3218 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.5B |
| IPO Year | 2014 | 2010 |
Fundamental Metrics
Financial Performance| Metric | XENE | FBP |
|---|---|---|
| Price | $62.35 | $29.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $68.55 | $25.50 |
| AVG Volume (30 Days) | 654.5K | ★ 1.6M |
| Earning Date | 05-08-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.36% |
| EPS Growth | N/A | ★ 18.78 |
| EPS | N/A | ★ 1.19 |
| Revenue | $311,000.00 | ★ $1,255,034,000.00 |
| Revenue This Year | N/A | $15.10 |
| Revenue Next Year | $2,496.48 | $4.65 |
| P/E Ratio | ★ N/A | $24.70 |
| Revenue Growth | N/A | ★ 2.38 |
| 52 Week Low | $35.60 | $19.16 |
| 52 Week High | $72.66 | $29.58 |
Technical Indicators
Market Signals| Indicator | XENE | FBP |
|---|---|---|
| Relative Strength Index (RSI) | 45.39 | 71.42 |
| Support Level | $61.16 | $28.63 |
| Resistance Level | $62.91 | N/A |
| Average True Range (ATR) | 2.15 | 0.43 |
| MACD | -0.39 | -0.06 |
| Stochastic Oscillator | 19.72 | 88.03 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Mortgage Banking; Consumer (Retail) Banking; Commercial and Corporate Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. The Consumer (Retail) Banking segment generates the majority of revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.